Dr. Gunn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The University of Texas MD Anderson Cancer Center, Division & Department of Radiation Oncology
Proton Therapy Center, 1840 Old Spanish Trail, Unit 1150
Houston, TX 77054Phone+1 713-563-2562Fax+1 713-563-2366
Summary
- Dr. G. Brandon Gunn is a Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center and the Associate Vice President-Radiation Oncology Medical Operations. He received his medical degree and graduated valedictorian from Texas Tech University Health Sciences Center, School of Medicine in Lubbock, Texas in 2004. Following completion of his clinical residency in Radiation Oncology at the University of Texas Medical Branch in Galveston, Texas, he joined the MD Anderson faculty in 2009. Dr. Gunn specializes in the management of patients with malignancies of the head and neck, including skull base, thyroid and skin cancers. He is dedicated to securing the best possible outcomes for his patients, by prioritizing a patient-centered approach, comprehensive multidisciplinary patient evaluation and care, attention to detail and quality assurance, clinical trial participation, and implementation of advanced radiation therapy approaches and technologies including intensity modulated proton therapy, volumetric arc radiation therapy, MRI-simulation and treatment planning, adaptive radiotherapy, and brachytherapy. Dr. Gunn leads numerous research efforts and clinical trials in patient reported outcomes, quality of life, patient symptom and toxicity reduction, proton therapy, aggressive thyroid malignancies, has over 200 scientific publications, and is the radiation oncology lead of the MD Anderson Head and Neck Cancer Symptom Working Group, radiation oncology lead of the Facilitating Anaplastic Thyroid Cancer Specialized Treatment (FAST) Team, and co-lead of the MD Anderson Head and Neck Cancer Service Line.
Education & Training
- University of Texas Medical Branch HospitalsResidency, Radiation Oncology, 2005 - 2009
- St. Joseph Medical CenterInternship, Transitional Year, 2004 - 2005
- Texas Tech University Health Sciences Center School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- GA State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Radiology Radiation Oncology
- Join now to see all
Clinical Trials
- Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. Start of enrollment: 2010 Jul 22
- Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer Start of enrollment: 2010 Oct 28
- Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer Start of enrollment: 2011 May 19
Publications & Presentations
PubMed
- 30 citationsTobacco exposure as a major modifier of oncologic outcomes in Human PapillomaVirus (HPV) associated oropharyngeal squamous cell carcinomaHesham Elhalawani, Abdallah S.R. Mohamed, Baher Elgohari, Timothy A. Lin, Andrew G. Sikora
BMC Cancer. 2020-09-23 - 14 citationsIntensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.J.Z. Cao, Xiaodong Zhang, Bo Jiang, Jiayun Chen, Xiaochun Wang
Radiotherapy and Oncology. 2021-04-08 - 18 citationsXerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.Alexander F. Bagley, Rong Ye, Adam S. Garden, Gary Brandon Gunn, David I. Rosenthal
Radiotherapy and Oncology. 2020-01-01
Journal Articles
- Symptom Burden Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Cancer SurvivorsC David Fuller, Ehab Y Hanna, Linda B Piller, G Brandon Gunn, Stephen Y Lai, Katherine A Hutcheson, Jan S Lewin, JAMA
- Decreased Gastrostomy Tube Incidence and Weight Loss After Transoral Robotic Surgery for Low‐ to Intermediate‐Risk Oropharyngeal Squamous Cell CarcinomaG Brandon Gunn, F Christopher Holsinger, Katherine A Hutcheson, Clifton D Fuller, Amy C Hessel, Adam S Garden, Michael E Kupferman, Head & Neck
- Comparing Intensity-Modulated Proton Therapy with Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey from Clinical Trial Concept to ActivationSteven J Frank, G Brandon Gunn, Adam S Garden, Katherine Hutcheson, Paul M Busse, Merrill S Kies, Nancy Y Lee, Alexander Lin, Erich M Sturgis, C David Fuller, J Jack L..., ScienceDirect
Press Mentions
- Skin Cancer Survivor Finds Courage, Support in Other PatientsJuly 27th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: